Printer Friendly

Research and Markets: Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition.

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/62a87e/royalty_financing) has announced the addition of the "Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition" report to their offering.

The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.

* Comprehensive directory of royalty financing deals since 2003

* Royalty financing contract documents

* Royalty financing agreement terms

* Royalty financing agreement structure

* Top royalty financing deals by value

* Most active Royalty financing dealmakers

The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the royalty financing agreements entered into by the worlds leading biopharma companies.

The report provides a detailed understand and analysis of how and why companies enter royalty financing partnering deals.

Understanding the flexibility of a prospective partners negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred contract documents provide this insight where press releases and databases do not.

This report contains over 150 links to online copies of actual royalty financing contract documents as submitted to the Securities Exchange Commission by biopharma companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partners flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Key benefits:

Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics provides the reader with the following key benefits:

* In-depth understanding of royalty financing partnering deal trends since 2000

* Analysis of the structure of royalty financing partnering agreements with numerous real life case studies

* Comprehensive listing of all royalty financing deals since 2003, together with deal terms, value and press release

* Comprehensive access to over 150 actual royalty financing partnering contracts entered into by the worlds biopharma companies

* Insight into the terms included in a royalty financing partnering agreement, together with real world clause examples

* Understand the key deal terms companies have agreed in previous deals

* Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope:

Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics is intended to provide the reader with an in-depth understanding of the royalty financing trends and structure of deals entered into by leading biopharma companies worldwide.

Royalty Financing Agreements in Pharma, Biotech and Diagnostics includes:

* Trends in royalty financing dealmaking in the biopharma industry since 2000

* Analysis of royalty financing deal structure

* Case studies of real-life royalty financing deals

* Comprehensive listing of royalty financing deals since 2003

* Access to over 150 royalty financing contract documents

* The leading royalty financing deals by value since 2000

* Most active royalty financing dealmakers since 2000

* The leading royalty financing partnering resources

In Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics, available contracts are listed by:

* Company A-Z

* Headline value

* Therapeutic area

Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Key Topics Covered:

Executive Summary

Chapter 1 Introduction

Chapter 2 Trends in royalty financing dealmaking

Chapter 3 Overview of royalty financing deal structure

Chapter 4 Leading royalty financing deals

Chapter 5 Royalty financing agreement directory 2003-early 2010

Chapter 6 Comprehensive royalty financing directory 2003-early 2010

For more information visit http://www.researchandmarkets.com/research/62a87e/royalty_financing
COPYRIGHT 2010 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 30, 2010
Words:610
Previous Article:Research and Markets: This Snapshot Czech Republic Pharmaceuticals 2009 Provides 2008 Year-End Market Size Data, With 2009 Estimates, 5 Years of...
Next Article:Rolls-Royce AE 3007A2 Engine Receives FAA Certification.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters